Company profile
TetraLogic Pharmaceuticals Corporation
OTC: TLOG · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 45GM —SS 35
v0.1 · 25/100 weight · pillars only
↑ filing timeliness, listing tenure · ↓ disclosure history, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$49.7M
Employees
29
as of 2026-08-31
Market cap
$979
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02015
Net income-$49.7M-$49.7M2015
Operating income-$45.0M-$45.0M2015
Total assets$64.0M$64.0M2015
Liabilities$70.0M$70.0M2015
Equity-$5.9M-$5.9M2015
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is TetraLogic Pharmaceuticals Corporation’s revenue?
TetraLogic Pharmaceuticals Corporation booked $0 in FY2015 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Lynx Global Digital Finance Corporation——Grupo International Inc.——Omnimmune Holdings, Inc.——BioELife Corp.——North Bud Farms Inc.——OncoSec Medical Incorporated——Neighbors
Chester →Key facts
CEOYigong Shi
SectorHealthcare
IndustryBiotechnology
HeadquartersMalvern, PA
ExchangeOTC: TLOG
Employees29
IPO date2013-12-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.